Skip to content

Phreesia PHR EV / sales

EV / sales at other companies

Veeva Systems logo
Veeva SystemsVEEV
7.1×-5.2×
Claritev Corporation logo
Claritev CorporationCTEV
Corvel logo
CorvelCRVL
2.7×-3.6×
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
0.7×+0.2×
ExlService Holdings logo
ExlService HoldingsEXLS
2.4×-1.8×
Evolent Health, Inc. logo
Evolent Health, Inc.EVH
0.6×-0.1×

Other financials

Income statement

See full
Revenue$130.9M+12.9%
Gross profit$113.3M+14.1%
Operating income$6.7M+305%
Net income$3.0M+176%
EPS (diluted)$0.05+171%

Balance sheet

See full
Cash & equivalents$73.8M-12.3%
Total debt$98.3M+242%
Total equity$359.1M+27.3%
Total assets$666.1M+66.4%

Cash flow

See full
Operating cash flow$23.9M+61.1%
CapEx$4.3M+23.0%
Free cash flow$19.6M+72.9%

Valuation

See full
Market cap$564.34M-63.8%
P/E61.5×
P/S1.1×-2.5×

Profitability

See full
Gross margin85.4%+0.8pp
Operating margin0.7%+0.4pp
Net margin1.9%+1.0pp
FCF margin15.3%+6.9pp

Returns & leverage

See full
Return on equity2.9%+1.5pp
Debt / equity0.3×+0.2×
Current ratio1.8×-0.2×

Where this comes from

Calculated from Phreesia’s reported figures.

Based on the most recent quarter.

The official record: Phreesia’s 10-Q, filed May 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Phreesia's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Phreesia's EV / sales?
Phreesia (PHR) reported EV / sales of 1.3× in Q1 2026.
How has Phreesia's EV / sales changed year-over-year?
Phreesia's EV / sales decreased by 58.3% year-over-year, from 3.2× to 1.3×.
What is the long-term trend for Phreesia's EV / sales?
Over 5 years (2021 to 2026), Phreesia's EV / sales has grown at a -39.2% compound annual growth rate (CAGR), from 21.2× to 1.8×.
What does EV / sales mean?
Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.